iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
3 hedge funds and large institutions have $33.2M invested in iPath Return on Disability ETN in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
4% more capital invested
Capital invested by funds: $31.9M → $33.2M (+$1.22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$68 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $33.2M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$68 | +1 | New |
|
RODI Hedge Fund Activity: Q3 2017 in Review
3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q3 2017, worth a combined $33.2M — up 3.8% from $31.9M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RODI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $68.
- 3 institutional investors held iPath Return on Disability ETN (RODI) as of Q3 2017, up from 2 in Q2 2017.
- Funds reported $33.2M of iPath Return on Disability ETN stock for Q3 2017, up 3.8% quarter-over-quarter.
- 1 fund opened new iPath Return on Disability ETN positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest iPath Return on Disability ETN buyer in Q3 2017 was UBS Group, an estimated $68 added.
Based on aggregated 13F filings for Q3 2017.